International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8002457
Original Article
To Assess Outcome of Neonates Born to Mothers with Hypertension Disorder of Pregnancy at Tertiary Care Hospital
 ,
 ,
Published
June 4, 2023
Abstract
Background: Gestational hypertension and preeclampsia are common disorders during pregnancy, with the majority of cases developing at or near term. The development of mild hypertension or preeclampsia at or near term is associated with minimal maternal and neonatal morbidities. In contrast, the onset of severe gestational hypertension and/or severe preeclampsia before 35 weeks' gestation is associated with significant maternal and perinatal complications Materials and Methods: The present study was a single-center, observational Study conducted on patients admitted with newborns born to mother with hypertensive disorder of pregnancy, Irrespective of treatment in the department of Paediatrics, Sri Siddhartha Medical College hospital and Research Centre, Tumkur from January 2020 to July 2022. Prior initiation of the study obtained Ethical and Research Committee clearance from Sri Siddhartha Medical College hospital and Research Centre, Tumkur. During present study total 200 neonates were reviewed in OPD/IP, among 125 patients were enrolled into the study according present study inclusion criteria and 75 patients were excluded according exclusion criteria. Results: Majority subjects were in the age group of 21-25 years (45.60 %).Most subjects were in their primi (48%).The above table gives data on distribution of subjects based on diagnosis. Most subjects were diagnosed with preeclampsia, i.e.73 (58.4%); followed by 27 subjects (21.6 %) with eclampsia HTN and 25 subjects (20%) with gestational HTN .Most subjects were not with any complications (87.2%). Most of the neonates were males (52%).There were 50.40 % neonates with low birth weight and 49.60 % with normal birth weight. 41.60 % neonates had morbidities. The morbidities observed in our study were resuscitation (33.60%); hypothermia (31.20%); hypoglycemia (28.00%); icterus (24.80 %); sepsis (14.40%); Transient tachypnea of the newborn (16 %); birth asphyxia (11.20%) and respiratory distress syndrome (57.60%). Majority of neonates required admission into Intensive Care Unit (54.4%). Conclusion: Pregnancy Induced Hypertension is a maternal pathology involving placental modification which is associated with fetal complications. Fetal morbidity and mortality are serious concerns in preeclampsia and are attributable to poor management. Neonatal adverse events such as asphyxia, low birth weight, prematurity, Intrauterine growth restriction, NICU admission, and neonatal death were more prevalent if the mother had a hypertensive disorder during pregnancy.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2430 Views
469 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved